The company known today as Teva Pharmaceutical Industries Ltd. was established in Jerusalem in 1901. It was started as a small wholesale drug business that distributeed imported medications. It specializes primarily in generic drugs, but other business include active pharmaceutical ingredients and to some extent proprietary pharmaceuticals. It is the largest generic drug manufacturer in the world.
Today they have a portfolio of more than 1,000 molecules, producing approximately 64 billion tablets and capsules a year at 66 manufacturing facilities. It ranks among the 10 top pharmaceutical companies in the world and is active in 60 countries. Approximately 43,000 employees work in Teva all around the world. They have the most extensive product portfolio in the industry: 1 in 7 generic prescriptions in the US are filled with Teva products, and on average, 2500 Teva packs are dispensed in the EU, every single minute of every single day. Teva is the leading global supplier of active pharmaceutical ingredients (APIs), the essential raw materials of the drug manufacturing industry.
- Sprintec and many more
|Traded as||NYSE: TEVA
|Headquarters||Petah Tikva, Israel|
|Key people||Erez Vigodman, President and Chief Executive Officer
Prof. Yitzhak Peterburg, Chairman
Eyal Desheh, Chief Financial Officer
|Revenue||US$20.3 billion (2014)|
|Net income||US$3.042 billion (2014)|
|Number of employees||46,000 (2012)|